December 2008 Volume 5 Number 12
Visit Nature Clinical Practice Oncology online to browse the journal.
Now available at http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0UgF0E6
=====================================================================
Announcing an open access option in British Journal of Cancer.
An open access option is now available to all authors of original
research papers that are accepted for publication in BJC. BJC OPEN
articles will be freely accessible to all readers immediately on
publication.
Learn more about BJC OPEN by visiting BJC online at
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CBLe0Ex
=====================================================================
----------------------
EDITORIAL
----------------------
The clinical trials system is broken
Vincent T DeVita Jr
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRC0EW
----------------------
RESEARCH HIGHLIGHTS
----------------------
Microfluid cell-capture chip isolates circulating tumor cells from
patients with NSCLC
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRE0EY
Novel bispecific antibody causes tumor regression in patients with
non-Hodgkin lymphoma
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRG0Ea
Predictors of response to erlotinib in patients with advanced NSCLC
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRI0Ec
First-degree relatives of patients with MPNs are at increased risk of
developing MPNs
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRK0Ee
Multigene assay predicts survival of patients with early-stage lung
adenocarcinoma
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRL0Ef
Surgical planes of dissection influence survival in patients treated
for colon cancer
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRN0Eh
RPN2 overexpression confers resistance to docetaxel in breast cancer
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRP0Ej
Patients with lymphocytosis might develop chronic lymphocytic leukemia
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRR0El
----------------------
PRACTICE POINTS
----------------------
Is intravenous iron supplementation with erythropoiesis-stimulating
agents beneficial in cancer patients with anemia?
Julia Bohlius
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRT0En
Thalidomide plus dexamethasone as primary therapy for newly diagnosed
patients with multiple myeloma
Meletios A Dimopoulos and Efstathios Kastritis
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRV0Ep
Anal cancer: is neoadjuvant cisplatin chemotherapy or chemoradiotherapy
friend or foe?
Robert Glynne-Jones and Suzannah Mawdsley
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRW0Eq
Determining the survival benefit of adjuvant radiotherapy in patients
with node-positive head and neck cancer
Giuseppe Sanguineti and Arlene A Forastiere
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRY0Es
Adoptive transfer of antigen-specific CD4+ T cells in the treatment of
metastatic melanoma
F Stephen Hodi and David E Fisher
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRa0E1
----------------------
VIEWPOINT
----------------------
The role of cytoreductive nephrectomy for renal cell carcinoma in the
era of targeted therapy
Simon Chowdhury, Peter G Harper and Toni K Choueiri
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRc0E3
----------------------
REVIEWS
----------------------
Precancerous lesions of the breast
Alberto Costa and Vittorio Zanini
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRe0E5
Drug Insight: cetuximab in the treatment of recurrent and metastatic
squamous cell carcinoma of the head and neck
Jacques Bernier
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRg0E7
Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous
T-cell lymphomas
Omar Khan and Nicholas B La Thangue
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRi0EA
Angiosarcoma of the breast following surgery and radiotherapy for breast
cancer
Rachel Abbott and Carlo Palmieri
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRj0EB
----------------------
CASE STUDY
----------------------
Complete response of stage IV anal mucosal melanoma expressing KIT
Val560Asp to the multikinase inhibitor sorafenib
Alfonso Quintas-Cardama, Alexander J Lazar, Scott E Woodman, Kevin Kim,
Merrick Ross and Patrick Hwu
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0CCRl0ED
=====================================================================
You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://ealerts.nature.com/cgi-bin24/DM/y/eozz0Xztnp0HjM0Zzu0EI
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact our customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
=====================================================================
